marketcaparena

CNSP

CNS Pharmaceuticals, Inc.

Company overview

Market capitalization
$7.47M
Employees
8
Latest publication
2026-09-29
About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue0USD0USD0USD0USD3,140USD3,140USD0USD0USD
Cost Of Revenue1,868USD-2,898USD697USD1,101USD1,100USD985USD751USD752USD
Gross Profit-1,868USD2,898USD-697USD-1,101USD-1,100USD-985USD-751USD-752USD
Research Development3,543,723USD3,165,162USD2,196,828USD1,167,045USD3,242,905USD1,498,176USD4,244,993USD1,116,562USD
Selling General Administrative1,431,482USD2,820,964USD1,056,560USD1,242,340USD1,094,755USD1,701,872USD1,383,913USD1,411,573USD
Total Operating Expenses4,973,337USD5,989,024USD3,252,691USD2,408,284USD4,336,560USD3,199,063USD5,628,155USD2,527,383USD
Operating Income-4,975,205USD-5,986,126USD-3,253,388USD-2,409,385USD-4,337,660USD-3,200,048USD-5,628,906USD-2,528,135USD
Interest Income44,270USD35,605USD37,023USD38,609USD42,548USD26,456USD25,230USD1,845USD
Interest Expense6,111USD2,721USD2,116USD4,185USD6,208USD2,774USD2,258USD4,463USD
Net Interest Income38,159USD32,884USD34,907USD34,424USD36,340USD23,682USD22,972USD-2,618USD
Income Before Tax-4,937,046USD-5,955,802USD-3,218,481USD-2,374,961USD-4,301,320USD-3,176,366USD-5,605,934USD-2,530,753USD
Net Income-4,937,046USD-5,955,802USD-3,218,481USD-2,374,961USD-4,301,320USD-3,176,366USD-5,605,934USD-2,530,753USD
Net Income From Continuing Ops-4,937,046USD-5,955,802USD-3,218,481USD-2,374,961USD-4,301,320USD-3,176,366USD-5,605,934USD-2,530,753USD
Ebit-4,975,205USD-5,953,081USD-3,216,365USD-2,370,776USD-4,295,112USD-3,173,592USD-5,603,676USD-2,526,290USD
Ebitda-4,973,337USD-5,952,061USD-3,215,668USD-2,369,675USD-4,294,012USD-3,172,607USD-5,602,925USD-2,525,538USD
Depreciation And Amortization1,868USD1,020USD697USD1,101USD1,100USD985USD751USD752USD
Reconciled Depreciation1,868USD1,020USD697USD1,101USD1,100USD985USD751USD752USD
Total Other Income Expense Net38,159USD30,324USD34,907USD34,424USD36,340USD23,682USD22,972USD-2,618USD
Selling And Marketing Expenses———————752USD
Income Tax Expense———————-2USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
Research Development9,771,940USD9,290,143USD14,095,606USD9,300,055USD9,805,075USD5,061,734USD1,854,334USD21,267USD
Selling General Administrative6,214,619USD5,611,800USD4,769,502USD5,967,052USD4,680,840USD4,392,873USD1,978,643USD860,520USD
Total Operating Expenses15,986,559USD14,898,637USD18,860,974USD14,921,213USD14,472,845USD9,443,511USD3,832,977USD881,787USD
Operating Income-15,986,559USD-14,901,943USD-18,865,108USD-14,932,969USD-14,485,915USD-9,454,607USD-3,832,977USD-881,787USD
Interest Income153,785USD60,262USD27,687USD0USD——44,230USD46,700USD
Interest Expense15,230USD16,119USD13,805USD7,027USD9,285USD3,264USD44,234USD46,697USD
Net Interest Income138,555USD44,142USD7,449USD-7,027USD-9,285USD-3,264USD-44,234USD-46,697USD
Income Before Tax-15,850,564USD-14,857,801USD-18,851,226USD-15,274,134USD-14,495,200USD-9,457,871USD-3,877,211USD-7,391,899USD
Net Income-15,850,564USD-14,857,801USD-18,851,226USD-15,274,134USD-14,495,200USD-9,457,871USD-3,919,490USD-7,391,899USD
Net Income From Continuing Ops-15,850,564USD-14,857,801USD-18,612,827USD-15,274,134USD-14,036,578USD-9,457,871USD-3,877,211USD-7,391,899USD
Ebit-15,835,334USD-14,841,681USD-18,865,108USD-15,267,107USD-14,485,915USD-9,454,607USD-3,832,977USD-7,345,198USD
Ebitda-15,831,416USD-14,838,375USD-18,860,974USD-15,255,351USD-14,472,845USD-9,443,511USD-3,831,022USD-6,463,411USD
Depreciation And Amortization3,918USD3,306USD4,134USD11,756USD13,070USD11,096USD1,955USD881,787USD
Reconciled Depreciation3,918USD3,306USD5,562USD11,756USD13,070USD11,096USD1,955USD—
Total Other Income Expense Net135,995USD44,142USD13,882USD-341,165USD-9,285USD-3,264USD-44,234USD-6,510,112USD
Cost Of Revenue—3,306USD4,134USD11,756USD13,070USD11,096USD1,955USD—
Gross Profit—-3,306USD-4,134USD-11,756USD-13,070USD-11,096USD-1,955USD—
Selling And Marketing Expenses——4,134USD—————
Income Tax Expense——-4USD7,027USD9,285USD3,264USD42,279USD46,697USD
Net Income Applicable To Common Shares————-14,036,578USD-9,457,871USD-3,877,211USD-7,391,899USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets21,938,000USD4,653,192USD8,623,466USD11,869,258USD14,507,875USD13,749,315USD8,700,943USD7,409,273USD
Cash And Equivalents19,985,000USD———————
Total Current Assets21,923,000USD4,051,091USD8,102,801USD11,391,735USD14,137,820USD13,722,026USD8,658,508USD7,388,098USD
Other Current Assets1,865,000USD1,100,214USD901,787USD1,527,648USD2,007,947USD674,434USD1,314,591USD414,974USD
Total Liabilities3,738,000USD———————
Total Current Liabilities3,738,000USD4,582,487USD4,100,910USD1,959,117USD1,382,890USD2,779,193USD2,524,332USD4,056,929USD
Total Stockholder Equity18,200,000USD70,705USD4,522,556USD9,910,141USD13,124,985USD10,970,122USD6,176,611USD3,352,344USD
Total Equity Including Noncontrolling Interest18,200,000USD———————
Property Plant Equipment Net15,000USD22,014USD17,703USD3,107USD3,804USD4,905USD6,005USD2,802USD
Accounts Payable3,738,000USD4,350,134USD—1,928,324USD1,261,123USD2,568,520USD2,198,260USD4,025,742USD
Common Stock2,000USD811USD633USD574USD504USD2,945USD1,414USD33,446USD
Retained Earnings-107,800,000USD-105,212,314USD-100,275,268USD-94,319,466USD-91,100,985USD-88,726,024USD-84,424,704USD-81,248,338USD
Total Liab—4,582,487USD4,100,910USD1,959,117USD1,382,890USD2,779,193USD2,524,332USD4,056,929USD
Capital Stock—811USD633USD574USD504USD2,945USD1,414USD33,446USD
Cash—2,950,877USD7,201,014USD9,864,087USD12,129,873USD13,047,592USD6,461,378USD6,973,124USD
Cash And Short Term Investments—2,950,877USD7,201,014USD9,864,087USD12,129,873USD13,047,592USD6,461,378USD6,973,124USD
Net Debt—-2,718,524USD-6,872,443USD-9,833,294USD-12,008,106USD-12,836,919USD-6,135,306USD-6,941,937USD
Short Term Debt—232,353USD328,571USD30,793USD121,767USD210,673USD326,072USD31,187USD
Short Long Term Debt—232,353USD328,571USD30,793USD121,767USD210,673USD326,072USD31,187USD
Short Long Term Debt Total—232,353USD328,571USD30,793USD121,767USD210,673USD326,072USD31,187USD
Common Stock Shares Outstanding—676,172shares443,369shares558,868shares370,128shares227,219shares117,796shares36,968shares
Non Current Assets Total—602,100USD520,665USD477,523USD370,055USD27,289USD42,435USD21,175USD
Non Current Liabilities Total—0USD0USD0USD0USD0USD0USD0USD
Non Currrent Assets Other—580,086USD502,962USD474,416USD366,251USD22,384USD36,430USD18,373USD
Net Working Capital—-504,148USD4,001,891USD9,432,618USD12,754,930USD10,942,833USD6,134,176USD3,331,169USD
Unclassified Equity—105,281,397USD104,796,558USD104,228,459USD104,224,962USD99,690,256USD90,598,487USD84,533,790USD
Other Current Liab——3,772,339USD1,928,324USD—2,568,520USD2,198,260USD8,051,484USD
Net Receivables——0USD0USD0USD882,539USD882,539USD—
Unclassified Current Liabilities———-1,959,117USD—-2,779,193USD-2,524,332USD-8,082,671USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets8,623,466USD8,700,943USD1,700,853USD13,053,115USD8,757,385USD15,853,412USD7,912,075USD683,333USD
Other Current Assets901,787USD1,314,591USD1,042,449USD2,509,238USD2,472,933USD1,456,350USD652,622USD305,397USD
Total Liab4,100,910USD2,524,332USD6,132,968USD4,920,259USD2,135,566USD1,905,428USD311,000USD1,232,631USD
Total Stockholder Equity4,522,556USD6,176,611USD-4,432,115USD8,132,856USD6,621,819USD13,947,984USD7,601,076USD-549,298USD
Other Current Liab3,772,339USD2,198,260USD5,832,162USD828,391USD224,949USD519,804USD21,500USD763,249USD
Common Stock633USD1,414USD6,214USD1,617USD27,927USD23,856USD16,450USD12,695USD
Capital Stock633USD1,414USD6,214USD1,617USD27,927USD23,856USD16,450USD12,695USD
Retained Earnings-100,275,268USD-84,424,704USD-69,566,903USD-50,715,677USD-34,982,921USD-20,946,343USD-11,488,472USD-7,611,261USD
Cash7,201,014USD6,461,378USD548,721USD10,055,407USD5,004,517USD14,039,493USD7,241,288USD282,736USD
Cash And Short Term Investments7,201,014USD6,461,378USD548,721USD10,055,407USD5,004,517USD14,039,493USD7,241,288USD282,736USD
Total Current Assets8,102,801USD8,658,508USD1,591,170USD12,564,645USD7,477,450USD15,495,843USD7,893,910USD588,133USD
Total Current Liabilities4,100,910USD2,524,332USD6,132,968USD4,920,259USD2,135,566USD1,905,428USD311,000USD1,232,631USD
Net Debt-6,872,443USD-6,135,306USD-247,915USD-9,645,439USD-4,616,723USD-13,600,199USD-7,241,288USD34,182USD
Short Term Debt328,571USD326,072USD300,806USD409,968USD387,794USD439,294USD—316,918USD
Short Long Term Debt328,571USD326,072USD300,806USD409,968USD387,794USD439,294USD—316,918USD
Short Long Term Debt Total328,571USD326,072USD300,806USD409,968USD387,794USD439,294USD—316,918USD
Net Receivables0USD882,539USD0USD—————
Property Plant Equipment Net17,703USD6,005USD4,933USD5,664USD16,109USD23,431USD18,165USD—
Common Stock Shares Outstanding443,369shares31,853shares126shares45shares29shares18shares18shares18shares
Non Current Assets Total520,665USD42,435USD109,683USD488,470USD1,279,935USD357,569USD18,165USD95,200USD
Non Current Liabilities Total0USD0USD0USD4,091,868USD1,910,617USD1,385,624USD289,499USD445,783USD
Non Currrent Assets Other502,962USD36,430USD104,750USD482,806USD1,263,826USD334,138USD0USD95,200USD
Net Working Capital4,001,891USD6,134,176USD-4,541,798USD7,644,386USD5,341,884USD13,590,415USD7,582,911USD-644,498USD
Unclassified Equity104,796,558USD90,598,487USD65,122,360USD58,845,299USD41,548,886USD34,846,615USD19,056,648USD7,036,573USD
Accounts Payable—2,198,260USD5,832,162USD3,681,900USD1,522,823USD946,330USD289,499USD128,865USD
Unclassified Current Liabilities—-2,524,332USD-6,132,968USD—————
Other Assets——1USD—1,263,826USD334,138USD—95,200USD
Current Deferred Revenue——-5,832,162USD————23,599USD
Unclassified Non Current Liabilities———4,091,868USD1,576,479USD1,051,486USD——
Deferred Long Term Liab————334,138USD334,138USD—95,200USD
Net Tangible Assets————6,621,819USD13,613,846USD7,601,076USD-549,298USD
Unclassified Non Current Assets————-1,263,826USD———
Good Will—————334,138USD——
Property Plant Equipment Gross—————23,431USD18,165USD—
Accumulated Other Comprehensive Income—————0USD0USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-4,937,046USD-5,955,802USD-3,218,481USD-2,374,961USD-4,301,320USD-3,176,366USD-5,605,934USD-2,530,753USD
Depreciation1,868USD1,020USD697USD1,101USD1,100USD985USD751USD752USD
Stock Based Compensation2,555USD85,068USD18,452USD21,841USD62,367USD129,900USD271,779USD234,345USD
Other Non Cash Items2,555USD3,817,293USD18,452USD—1USD1USD-672,193USD234,345USD
Change In Working Capital284,005USD-999,349USD1,025,161USD-2,991,241USD995,946USD-2,425,379USD-794,393USD645,263USD
Total Cash From Operating Activities-4,648,618USD-3,051,770USD-2,174,170USD-5,343,260USD-3,241,907USD-5,470,859USD-6,799,990USD-1,650,393USD
Capital Expenditures-6,182USD-18,175USD0USD0USD-4,188USD-4,188USD-3USD-3USD
Free Cash Flow-4,654,800USD-3,069,945USD-2,174,170USD-5,343,260USD-3,241,907USD-5,475,047USD-6,799,990USD-1,650,390USD
Total Cashflows From Investing Activities-6,179USD-18,175USD——-4,188USD-4,188USD——
Net Borrowings-96,218USD-30,791USD-90,974USD-88,906USD-86,882USD-31,187USD-92,061USD—
Total Cash From Financing Activities404,660USD406,872USD-91,616USD4,425,541USD9,828,121USD4,963,301USD12,281,555USD2,326,726USD
Sale Purchase Of Stock0USD-1,114USD557USD0USD-557USD—0USD0USD
Issuance Of Capital Stock500,878USD501,745USD0USD4,511,664USD9,033,021USD5,004,489USD12,413,616USD2,424,411USD
Change In Cash-4,250,137USD-2,663,073USD-2,265,786USD-917,719USD6,586,214USD-511,746USD5,481,565USD676,333USD
Begin Period Cash Flow7,201,014USD9,864,087USD12,129,873USD13,047,592USD6,461,378USD6,973,124USD1,491,559USD815,226USD
End Period Cash Flow2,950,877USD7,201,014USD9,864,087USD12,129,873USD13,047,592USD6,461,378USD6,973,124USD1,491,559USD
Other Cashflows From Financing Activities—-64,082USD-1,486USD2,783USD882,539USD-10,000USD-40,000USD-7,829USD
Unclassified Financing Cash Flow———4,511,664USD9,033,021USD—12,413,616USD2,334,555USD
Investments—————-4,188USD——
Other Cashflows From Investing Activities——————3USD-3USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-15,850,564USD-14,857,801USD-18,851,226USD-15,274,134USD-14,495,200USD-9,457,871USD-3,877,211USD-7,391,899USD
Depreciation3,918USD3,306USD4,134USD11,756USD13,070USD11,096USD1,955USD1,955USD
Stock Based Compensation187,728USD838,957USD1,007,417USD1,202,966USD1,723,842USD1,293,392USD477,096USD110,240USD
Other Non Cash Items2,559USD596,113USD498USD337,249USD714,867USD1,583USD270,307USD6,481,497USD
Change In Working Capital1,845,252USD-3,693,874USD3,699,146USD3,164,348USD-780,021USD833,782USD-425,619USD83,777USD
Total Cash From Operating Activities-13,811,107USD-17,113,299USD-14,140,031USD-10,557,815USD-13,538,309USD-7,318,018USD-3,553,472USD-716,385USD
Capital Expenditures-18,175USD-4,188USD-3,901USD-4,422USD-5,748USD-17,945USD-20,120USD-5USD
Free Cash Flow-13,829,282USD-17,117,487USD-14,143,932USD-10,562,237USD-13,544,057USD-7,335,963USD-3,573,592USD-716,385USD
Total Cashflows From Investing Activities-18,175USD-4,188USD-3,901USD-4,422USD-5,748USD-17,945USD-20,120USD-20,120USD
Net Borrowings-297,553USD-300,806USD-438,733USD-427,700USD-477,490USD-88,081USD-35,000USD886,675USD
Total Cash From Financing Activities14,568,918USD23,030,144USD4,637,246USD15,613,127USD4,509,081USD14,134,168USD10,259,747USD1,160,975USD
Sale Purchase Of Stock-2,043USD0USD———14,222,249USD10,294,750USD390,500USD
Issuance Of Capital Stock14,046,430USD23,376,375USD7,514,265USD16,038,093USD4,653,821USD14,222,249USD10,294,747USD390,500USD
Change In Cash739,636USD5,912,657USD-9,506,686USD5,050,890USD-9,034,976USD6,798,205USD6,686,155USD444,590USD
Begin Period Cash Flow6,461,378USD548,721USD10,055,407USD5,004,517USD14,039,493USD7,241,288USD555,133USD110,543USD
End Period Cash Flow7,201,014USD6,461,378USD548,721USD10,055,407USD5,004,517USD14,039,493USD7,241,288USD555,133USD
Other Cashflows From Financing Activities818,457USD-45,425USD2,758,380USD2,734USD332,750USD-45,000USD10,259USD470,475USD
Unclassified Financing Cash Flow14,050,057USD23,376,375USD-5,196,666USD—————
Investments—-4,188USD-1,743USD-4,422USD-5,748USD-17,945USD-20,120USD—
Change To Liabilities————576,493USD1,155,135USD153,609USD71,368USD
Cash And Cash Equivalents Changes—————6,798,205USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.